Psychemedics Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMD research report →
Price Chart
About the company
Established in 1986 and based in Acton, Massachusetts, Psychemedics Corporation specializes in providing comprehensive drug abuse detection services. The company operates across the United States, Brazil, and various international locations, employing hair sample analysis to identify a broad spectrum of substances. Their rigorous testing methodology involves both initial screening and confirmatory analysis through mass spectrometry, adhering to recognized industry standards.
- CEO
- Brian Hullinger
- IPO
- 1987
- Employees
- 116
- HQ
- Acton, MA, US
Get TickerSpark's AI analysis on PMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $15.56M
- P/E
- -8.34
- PEG
- -0.12
- P/S
- 0.79
- P/B
- 3.05
- EV/EBITDA
- 80.17
- Div Yield
- 0.00%
- Gross Margin
- 36.07%
- Op Margin
- -9.62%
- Net Margin
- -9.45%
- ROE
- -31.54%
- ROIC
- -29.20%
Latest fiscal year · YoY change
- Revenue
- $19.68M-10.9%
- Gross Profit
- $7.10M-15.6%
- Op Income
- $-1,893,000
- Net Income
- $-1,861,000+55.2%
- EPS
- $-0.32+55.6%
- OCF Growth
- +162.8%
- FCF Growth
- +151.4%
- 52W High
- $2.67
- 52W Low
- $2.60
- 50D MA
- $2.10
- 200D MA
- $2.23
- Beta
- 0.67
- RSI (14)
- 73
- Avg Volume
- 31.05K
No earnings-call transcripts are available for PMD yet.
- Free Float
- 73.9%
- Shares Outstanding
- 5.83M
- Float Shares
- 4.31M
of shares held by institutions
21 13F filers
Buy/sell ratio 9.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock Inc. | 71.02K | ▼ 5.73K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 17, 24 | Powell Anderson Capital Partners LLC | buy | 9,850 |
| Dec 16, 24 | Powell Anderson Capital Partners LLC | buy | 30,000 |
| Dec 13, 24 | Powell Anderson Capital Partners LLC | buy | 80,000 |
| Dec 17, 24 | Powell Anderson Capital Partners LLC | buy | 9,850 |
| Dec 16, 24 | Powell Anderson Capital Partners LLC | buy | 30,000 |
| Dec 12, 24 | Powell Anderson Capital Partners LLC | buy | 75,000 |
| Dec 11, 24 | Powell Anderson Capital Partners LLC | buy | 4,518 |
| Dec 10, 24 | Powell Anderson Capital Partners LLC | buy | 7,473 |
| Dec 10, 24 | Kamin Peter | sell | 320,708 |
| Dec 4, 24 | Powell Anderson Capital Partners LLC | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PMD coverage
Recent articles, reports, and earnings notes.
No research on PMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PMD report →Psychemedics Releases 2026 Workforce Insights Report
globenewswire.com · Apr 30
Psychemedics Releases 2025 Workforce Insights Report
globenewswire.com · Jun 16
Psychemedics Named “Most Innovative Drug Testing Company of the Year”
globenewswire.com · May 16
Psychemedics Corporation Announces Reverse and Forward Stock Split
globenewswire.com · Dec 2
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
globenewswire.com · Nov 12
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
globenewswire.com · Sep 26
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
globenewswire.com · Aug 13
Psychemedics Corporation's Board of Directors Approves Plan to Terminate Registration of Its Common Stock
globenewswire.com · Aug 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.